Hein, A., Lambrechts, D., von Minckwitz, G., Häberle, L., Eidtmann, H., Tesch, H., Untch, M., Hilfrich, J., Schem, C., Rezai, M., Gerber, B., Dan Costa, S., Blohmer, J., Schwedler, K., Kittel, K., Fehm, T., Kunz, G., Beckmann, M. W., Ekici, A. B., Hanusch, C., Huober, J., Liedtke, C., Mau, C., Moisse, M., Müller, V., Nekljudova, V., Peuteman, G., Rack, B., Rübner, M., Van Brussel, T., Wang, L., Weinshilboum, R. M., Loibl, S., & Fasching, P. A. (n.d.). genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study. International journal of cancer, 137(12), 2981–2988. http://access.bl.uk/ark:/81055/vdc_100026664499.0x000017